𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice

✍ Scribed by Nigel Irwin; Kerry Hunter; Norma Frizzell; Peter R. Flatt

Book ID
113587367
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
646 KB
Volume
581
Category
Article
ISSN
0014-2999

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the subchronic antidiabeti
Comparison of the subchronic antidiabetic effects of DPP IV–resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice
✍ Nigel Irwin; Paula L. McClean; Peter R. Flatt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract Glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) are the two key incretin hormones released from the gastrointestinal tract that regulate blood glucose homeostasis through potent insulin secretion. The rapid degradation of GIP and GLP‐1 by the ubiqu

Comparison of the anti-diabetic effects
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1–39)amide
✍ Nigel Irwin; Paula L. McClean; Roslyn S. Cassidy; Finbarr P. M. O'Harte; Brian D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract ## Background The two major incretin hormones, glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) are being actively explored as anti‐diabetic agents because they lower blood glucose through multiple mechanisms. The rapid inactivation of GIP and GLP‐